Loading...
Loading...
- Spark Therapeutics Inc ONCE spiked to $77.40 in premarket trading.
- All time high made in March at $79.50.
- Catalyst being a pivotal Phase 3 trial of SPK-RPE65 for genetic blinding conditions.
- Last week traded as low as $38.48 before ending the week at $43,93.
- Following a rally to $66 off the open, profits takers have come in.
- Currently, trading higher by $10 at $53.93.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in